Balogh; Maria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Balogh; Maria.The latest application filed is for "pyrazole derivatives and use thereof as orexin receptor antagonists".

Company Profile

0.7.7

Balogh; Maria - Dunakeszi HU
Balogh; Maria - Budapest HU
Balogh, Maria - Bunakeszi HU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazole Derivatives And Use Thereof As Orexin Receptor Antagonists App 20110059964 - Aletru; Michel ; et al.	2011-03-10
Pyrimidine derivatives as orexin receptor antagonists Grant 7,812,031 - Aranyi , et al. October 12, 2	2010-10-12
Imidazoquinoline derivatives as adenosine A3 receptor ligands Grant 7,709,489 - Aranyi , et al. May 4, 2	2010-05-04
Pyrazole derivatives and use thereof as orexin receptor antagonists Grant 7,659,298 - Aletru , et al. February 9, 2	2010-02-09
Imidazoquinoline Derivatives As Adenosine A3 Receptor Ligands App 20080255110 - ARANYI; Peter ; et al.	2008-10-16
Imidazoquinoline derivatives as adenosine A3 receptor ligands Grant 7,419,977 - Aranyi , et al. September 2, 2	2008-09-02
Pyrimidine Derivatives As Orexin Receptor Antagonists App 20070043037 - ARANYI; Peter ; et al.	2007-02-22
Imidazoquinoline derivatives and their use as adenosine A3 ligands Grant 7,176,213 - Aranyi , et al. February 13, 2	2007-02-13
Pyrazole Derivatives And Use Thereof As Orexin Receptor Antagonists App 20070021459 - ALETRU; Michel ; et al.	2007-01-25
Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands Grant 6,969,723 - Aranyi , et al. November 29, 2	2005-11-29
Imidazoquinoline derivatives as adenosine A3 receptor ligands App 20050234056 - Aranyi, Peter ; et al.	2005-10-20
Imidazoquinoline derivatives App 20050070566 - Aranyl, Peter ; et al.	2005-03-31
Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands App 20040186133 - Aranyl, Peter ; et al.	2004-09-23
Prolylendopeptidase inhibitors Grant 6,191,161 - Kanai , et al. February 20, 2	2001-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.